Sector: Pharmaceuticals & Biotechnology

Small Cap

Kabra Drugs Share Price

Kabra Drugs Ltd.

₹24.20

-1.02(-4.04%)

Trade Now

29th May 2026 | 3:25 PM

NSE :

Open Free Demat Account

Kabra Drugs Performance

Price Movement

N/A

₹23.16

₹25.44

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹25.44

Low₹23.16

Open at₹25.44

Prev Close₹25.22

Volumes1.84 L

Avg Price₹24.52

Lower Circuit₹21.96

Upper Circuit₹26.84

Historical Performance

3M High₹32.07

3M Low₹23.16

1 Yr High₹35.52

1 Yr Low₹11.63

3 Yr High₹35.52

3 Yr Low₹3.18

5 Yr High₹35.52

5 Yr Low₹2.95

Kabra Drugs Fundamentals

Market Cap

Low in industry

57.40 Cr.

PE Ratio (TTM)

Below industry Median

13.40

Dividend Yield

Net Profit TTM

332.4% incr over last year

4.30

Net Profit Growth

332.4% incr over last year

4.30

PEG Ratio

Below industry Median

ROE

-4.40

Operating Revenue TTM

57.33

Operating Revenue Growth

Book Value

Below industry Median

MFI

MFI is mid-range

44.67

RSI

RSI is mid-range

43.84

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

Kabra Drugs Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	30.42	19.76	7.15	0	0
Operating Expense	27.99	17.73	7.66	0.24	0.53
Operating Profit	2.43	2.04	-0.51	-0.24	-0.53
Depreciation	0.01	0.01	0	0.01	0
Interest	0	0	0	0	0
Tax	0.40	0.37	0	0	0
Net Profit	2.57	1.84	-0.50	0.39	-0.54

Kabra Drugs Technicals

Kabra Drugs Ltd. EMA & SMA

₹24.20

-1.02 (-4.04%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹24.6

Day EMA10 ₹24.7

Day EMA12 ₹24.8

Day EMA20 ₹25.1

Day EMA26 ₹25.4

Day EMA50 ₹26.2

Day EMA100 ₹26.5

Day EMA200 ₹24.2

Kabra Drugs Support and Resistance

Resistance

First Resistance₹25.51

Second Resistance₹26.61

Third Resistance₹27.79

Support

First Support₹23.23

Second Support₹22.05

Third Support₹20.95

Technical Indicators

Day RSI43.84

Day MFI44.67

Day ADX13.65

Day Commodity Channel Index-91.60

William-72.38

Day MACD-0.57

Day MACD Signal Line-0.60

Day ATR1.98

Day ROC125-13.75

Day ROC21-2.05

Kabra Drugs Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	0	0	0	0	0	0
FII	0	0	0	0	0	0
DII	0	0	0	0	0	0
Public	100	100	100	100	100	100

Kabra Drugs Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	1.26 L	1.55 L	80.94%
Week	73.01 K	1.04 L	69.98%
1 Month	57.87 K	82.37 K	70.25%
6 Month	1.05 L	1.16 L	90.46%

Kabra Drugs SWOT Analysis

Strengths17

Weakness7

Opportunity1

Threats0

MACD Crossover Above Signal Line

Undervalued Growth Stocks

Upcoming results for Nifty500 companies with previous quarter net profit growth greater than 10% YoY and QoQ

Consistent high performing stocks over Five Years

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with Low Debt

Increasing Revenue every quarter for the past 3 quarters

Increasing profits every quarter for the past 2 quarters

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Companies with Zero Promoter Pledge

Highest Recovery from 52 Week Low

MACD crossed above signal line previous end of day

Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes

Volume Shockers

Kabra Drugs Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Kabra Drugs Stock Comparison

Financials	Goldline Pharmaceutical Ltd.	Sai Parenterals Ltd.	Speciality Medicines Ltd.	Accretion Nutraveda Ltd.	Rekvina Laboratories Ltd.	Vivimed Labs Ltd.
Price (₹)	₹48.44	₹484.30	₹222	₹261.50	₹44.25	₹6.73
% Change	4.98%	-0.09%	1.49%	-0.91%	4.98%	4.34%
Revenue TTM (₹ Cr)	-	-	-	-	₹1.27	₹83.60
Net Profit TTM (₹ Cr)	-	-	-	-	₹-0.25	₹-34.95
PE TTM	16.40	-	15.00	37.40	-104.70	-1.60
1 Year Return		23.95			883.33	572
ROCE	-	3.56	-	-	-	-5.63

Similar Stocks

APPL

Aptus Pharma Ltd.

₹ 185.30

+4.99%

AMANTA

Amanta Healthcare Ltd.

₹ 126.00

-4.40%

AHCL

Anlon Healthcare Ltd.

₹ 13.75

-3.51%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 85.10

-2.20%

APL

Asston Pharmaceuticals Ltd.

₹ 73.01

+0.00%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 556.30

-0.65%

ASTONEALAB

Astonea Labs Ltd.

₹ 230.05

-0.20%

AMWILL

Amwill Health Care Ltd.

₹ 32.70

+1.18%

INNOVACAP

Innova Captab Ltd.

₹ 844.05

-0.25%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 79.40

-0.77%

SHELTER

Shelter Pharma Ltd.

₹ 32.20

+7.33%

TLL

Trident Lifeline Ltd.

₹ 248.00

-0.22%

DPL

Dipna Pharmachem Ltd.

₹ 7.40

-4.52%

ACHYUT

Achyut Healthcare Ltd.

₹ 5.76

+1.05%

SIGACHI

Sigachi Industries Ltd.

₹ 21.29

+2.85%

WINDLAS

Windlas Biotech Ltd.

₹ 826.85

+0.87%

VINEETLAB

Vineet Laboratories Ltd.

₹ 34.00

-2.86%

CBPL

Chandra Bhagat Pharma Ltd.

₹ 44.00

+0.00%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 530.60

-2.78%

RAJNISH

Rajnish Wellness Ltd.

₹ 0.45

+0.00%

ZIMLAB

Zim Laboratories Ltd.

₹ 101.00

-1.11%

BPLPHARMA

Bharat Parenterals Ltd.

₹ 1345.00

+2.90%

MEDICO

Medico Remedies Ltd.

₹ 47.93

-2.10%

FAQ's on KABRADG

What is the Market Capitalization of Kabra Drugs Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 2 June 2025, the market cap for Kabra Drugs Ltd. is approximately ₹ 57.4 Cr.

What are the PE and PB ratios for Kabra Drugs Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Kabra Drugs Ltd. is 13.4, and the Price-to-Book (PB) ratio is 2.

What is the 52-Week High and Low for Kabra Drugs Ltd.?

Over the past 52 weeks, the highest price reached by Kabra Drugs Ltd. shares was ₹ 35.52, and the lowest price was ₹ 11.63.

Who are the major shareholders of Kabra Drugs Ltd.?

Significant shareholdings in Kabra Drugs Ltd. typically include entities such as:

Public
Promoter
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Kabra Drugs Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Kabra Drugs Ltd. is often compared with other major players such as Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy